These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 8756098)
1. Implications of prominent cytologic dysplasia persisting in the marrow of a patient with CML even after the spontaneous disappearance of the Philadelphia chromosome. Janković GM; Bogdanović AD; Colović MD; Novak AV; Andolina M; Anagnostopoulos A Am J Hematol; 1996 Jul; 52(3):234-5. PubMed ID: 8756098 [No Abstract] [Full Text] [Related]
2. Philadelphia chromosome-positive thrombocythemia without features of chronic myeloid leukemia (CML) in peripheral blood. Girodon F; Bailly F; Barry M; Favre B; Carli PM; Mugneret F; Teyssier JR; Maynadié M Ann Hematol; 2005 Jun; 84(6):409-10. PubMed ID: 15692837 [No Abstract] [Full Text] [Related]
3. [Detection of the Mbcr/abl translocation using FISH in bone marrow samples from patients diagnosed with CML and ALL]. Vargas MT; Fernández-Novoa MC; García-Creus MD; González-Ruano J Sangre (Barc); 1996 Oct; 41(5):399-400. PubMed ID: 9026927 [No Abstract] [Full Text] [Related]
4. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression. Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous splenic rupture in atypical (Philadelphia chromosome negative) chronic myeloid leukaemia following blastic crisis. Sachithanandan A; Gleadhill I; Alexander HD; Morris TC Ir Med J; 2003 Jun; 96(6):181-2. PubMed ID: 12926761 [TBL] [Abstract][Full Text] [Related]
6. Sequestration of Philadelphia chromosome-positive cells in the bone marrow of a chronic myeloid leukemia patient in very prolonged remission. Birnie GD; MacKenzie ED; Goyns MH; Pollock A Leukemia; 1990 Jun; 4(6):452-4. PubMed ID: 2359346 [No Abstract] [Full Text] [Related]
7. [Chronic myeloid leukemia. Karyotype changes]. Rojas-Atencio A; Pineda-Del Villar L; Avila-León E; González-Ferrer S; Prieto-Carrasquero M; Soto M; González R Invest Clin; 1996 Sep; 37(3):167-75. PubMed ID: 8983354 [TBL] [Abstract][Full Text] [Related]
8. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome. Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058 [TBL] [Abstract][Full Text] [Related]
9. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia]. Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504 [TBL] [Abstract][Full Text] [Related]
11. [Detection of bcr/abl gene expression on bone marrow cell colonies in chronic myelogenous leukemia by reverse transcriptase-polymerase chain reaction]. Luo Z; Chen H; Luo S; Tang L; Wang J Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):418-20. PubMed ID: 12080671 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of genetic markers in chronic myelogenous leukemia patients after bone marrow transplantation. Zámecníková A; Kri an P; Mistrík M Neoplasma; 2000; 47(5):299-302. PubMed ID: 11130247 [TBL] [Abstract][Full Text] [Related]
13. Three-way Philadelphia variant t(9;22;14)(q34;q11.2;p11) in chronic myeloid leukemia. Park TS; Song J; Lee KA; Kim J; Choi JH; Choi JR; Kim SJ; Min YH Cancer Genet Cytogenet; 2009 May; 191(1):55-6. PubMed ID: 19389511 [No Abstract] [Full Text] [Related]
14. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients. Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410 [TBL] [Abstract][Full Text] [Related]
15. Marrow fibrosis associated with a Philadelphia chromosome. Nowell PC; Kant JA; Finan JB; Cassileth PA; Hanson CA Cancer Genet Cytogenet; 1992 Mar; 59(1):89-92. PubMed ID: 1372840 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion. Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603 [TBL] [Abstract][Full Text] [Related]
17. BCR-ABL positive essential thrombocythaemia: a variant of chronic myelogerous leukaemia or a distinct clinical entity: a special case report. Fadilah SA; Cheong SK Singapore Med J; 2000 Dec; 41(12):595-8. PubMed ID: 11296785 [TBL] [Abstract][Full Text] [Related]
18. An inv(16) in Ph-negative cells of a chronic myelogenous leukemia patient after imatinib treatment. Rowe LR; Brothman AR; Nibley WE; Gaffney MR; Chen Z Cancer Genet Cytogenet; 2007 Apr; 174(1):54-6. PubMed ID: 17350467 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous remission in a patient with chronic myelogenous leukemia. Musashi M; Abe S; Yamada T; Tanaka J; Gotohda Y; Maeda S; Sato Y; Morioka M; Sakurada K; Minagawa T; Asaka M; Miyazaki T N Engl J Med; 1997 Jan; 336(5):337-9. PubMed ID: 9011786 [No Abstract] [Full Text] [Related]
20. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status. Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]